News

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...
Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...
US regulators have fully approved Moderna's Spikevax COVID-19 vaccine for children aged 6 months to 11 years, but only for ...
A voluntary recall has been issued for select Ritz Peanut Butter Cracker Sandwiches that may be incorrectly labeled and cause severe allergic reactions.
FDA Commissioner told NewsNation the agency is focused on fighting childhood obesity and diabetes. Dr. Marty Makary discussed ...
The purchase of the Providence spinoff bolsters Samsung’s push to unify health data, including through wearables like the ...
A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.
The president hasn’t named a successor to Jerome H. Powell, but his insistence on someone who will lower interest rates has ...
Oncologists were one of the few provider groups to register support for the FDA rule, reflecting the challenge of assessing rapidly expanding cancer test offerings.
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
New Technological Processes and FDA Approvals Highlight AI and IoT Integration" BOSTON, July 10, 2025 /PRNewswire/ -- According to the latest ...
SILVER SPRING, MD — The FDA gives full approval for Moderna’s COVID-19 vaccine in children aged 6 months through 11 years who ...